hackint0sh/temp-data huggingface dataset:
protocolSection identificationModule nctId: NCT06319508, orgStudyIdInfo id: SGB-NT, briefTitle: Stellate Ganglion Block in Cerebral Palsy, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-03, primaryCompletionDateStruct date: 2024-12, completionDateStruct date: 2024-12, studyFirstPostDateStruct date: 2024-03-20, lastUpdatePostDateStruct date: 2024-03-20, sponsorCollaboratorsModule leadSponsor name: Copka Sonpashan, class: OTHER_GOV, descriptionModule briefSummary: The goal of this clinical trial is to test the efficacy of stellate ganglion block in children with cerebral palsy and dysphagia. The main question it aims to answer are:• Can stellate ganglion block improve the dysphagia of children with cerebral palsy? Participants were randomly divided into two groups, all provided with routine therapy. Based on this, the experimental group was given stellate ganglion block. The video fluoroscopic swallowing study was done to test the swallowing function before and after the study., conditionsModule conditions: Cerebral Palsy, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: QUADRUPLE, whoMasked: PARTICIPANT, whoMasked: CARE_PROVIDER, whoMasked: INVESTIGATOR, whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 80, type: ESTIMATED, armsInterventionsModule interventions name: routine rehabilitation treatment, interventions name: Stellate ganglion block, interventions name: Lidocaine hydrochloride, interventions name: Placebo injection, outcomesModule primaryOutcomes measure: Penetration-Aspiration Scale, secondaryOutcomes measure: Swallowing duration, secondaryOutcomes measure: Functional Oral Intake Scale, eligibilityModule sex: ALL, minimumAge: 4 Years, maximumAge: 7 Years, stdAges: CHILD, hasResults: False
protocolSection identificationModule nctId: NCT06319495, orgStudyIdInfo id: SGB-CSVD, briefTitle: Stellate Ganglion Block in Patients With Cerebral Small Vessel Disease, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-03, primaryCompletionDateStruct date: 2024-12, completionDateStruct date: 2024-12, studyFirstPostDateStruct date: 2024-03-20, lastUpdatePostDateStruct date: 2024-03-20, sponsorCollaboratorsModule leadSponsor name: Copka Sonpashan, class: OTHER_GOV, descriptionModule briefSummary: This is a prospective study conducted on patients with Cerebral Small Vessel Disease, dysphagia and cognitive impairment. They were divided into the comparison group and observation group evenly. All the patients were provided with routine therapy, while the patients in the observation group were given Stellate Ganglion Block. The swallowing function, cognitive function and activities of daily living of the two groups of patients before and after treatment were evaluated by Penetration-Aspiration Scale, Mini-mental state examination and modified Barthel index., conditionsModule conditions: Cerebral Small Vessel Diseases, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: QUADRUPLE, whoMasked: PARTICIPANT, whoMasked: CARE_PROVIDER, whoMasked: INVESTIGATOR, whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 80, type: ESTIMATED, armsInterventionsModule interventions name: Rehabilitation therapy, interventions name: Stellate ganglion block, interventions name: Lidocaine Hydrochloride, interventions name: placebo injection, outcomesModule primaryOutcomes measure: Penetration-Aspiration Scale, secondaryOutcomes measure: Modified Barthel Index, secondaryOutcomes measure: Mini-Mental State Examination, secondaryOutcomes measure: Functional Oral Intake Scale, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule, hasResults: False
protocolSection identificationModule nctId: NCT06319482, orgStudyIdInfo id: Adherence Study, briefTitle: The Adherence of Proactive Sleep Apnea Therapy, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-04-15, primaryCompletionDateStruct date: 2025-08-01, completionDateStruct date: 2025-08-01, studyFirstPostDateStruct date: 2024-03-20, lastUpdatePostDateStruct date: 2024-03-20, sponsorCollaboratorsModule leadSponsor name: NovaResp Technologies Inc, class: INDUSTRY, descriptionModule briefSummary: The goal of this clinical trial is to compare the adherence to Positive Airway Pressure (PAP) therapy for newly diagnosed Obstructive Sleep Apnea (OSA) patients. The main question(s) it aims to answer are:1. To compare the adherence of proactive therapy and conventional Automatic-PAP (APAP) therapy short-term (3 months) and long-term (12 months) for newly diagnosed OSA patients.2. To compare health outcomes (AHI, nightly pressure, and patient-reported outcomes) between proactive therapy and conventional APAP therapy., conditionsModule conditions: Obstructive Sleep Apnea, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: DOUBLE, whoMasked: PARTICIPANT, whoMasked: CARE_PROVIDER, enrollmentInfo count: 200, type: ESTIMATED, armsInterventionsModule interventions name: Proactive CPAP Therapy, interventions name: Conventional APAP Therapy, outcomesModule primaryOutcomes measure: Adherence, secondaryOutcomes measure: Apnea-Hypopnea Index, secondaryOutcomes measure: Pressure, secondaryOutcomes measure: Self-assessed sleep outcomes, secondaryOutcomes measure: Self-assessed functional outcomes, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 70 Years, stdAges: ADULT, stdAges: OLDER_ADULT, hasResults: False
protocolSection identificationModule nctId: NCT06319469, orgStudyIdInfo id: FMBSUREC/06122022/Mohamed, briefTitle: The Additive Value of Pyridostigmine to Silodosin in Acute Urinary Retention, statusModule overallStatus: COMPLETED, startDateStruct date: 2023-02-01, primaryCompletionDateStruct date: 2024-01-30, completionDateStruct date: 2024-01-30, studyFirstPostDateStruct date: 2024-03-20, lastUpdatePostDateStruct date: 2024-03-20, sponsorCollaboratorsModule leadSponsor name: Beni-Suef University, class: OTHER, descriptionModule briefSummary: Acute urine retention, AUR, is often considered the most serious consequence of aging men with progressive benign prostatic hyperplasia (BPH). AUR is defined as the sudden and painful inability to void freely. This study aims to evaluate whether pyridostigmine bromide added to silodosin is beneficial in treating acute urine retention caused by BPH., conditionsModule conditions: Prostatic Hyperplasia, designModule studyType: INTERVENTIONAL, phases: PHASE2, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 140, type: ACTUAL, armsInterventionsModule interventions name: silodosin 8 mg capsule and the pyridostigmine bromide 60 mg tablet, interventions name: silodosin 8 mg capsule, outcomesModule primaryOutcomes measure: International Prostate Symptom Score (IPSS), eligibilityModule sex: MALE, minimumAge: 50 Years, maximumAge: 80 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Beni-Seuf University Hospital, city: Banī Suwayf, country: Egypt, geoPoint lat: 29.07441, lon: 31.09785, hasResults: False
protocolSection identificationModule nctId: NCT06319443, orgStudyIdInfo id: STUDY00019235, briefTitle: Daily Vinegar Ingestion and 24-Hour Blood Glucose Control, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-03, primaryCompletionDateStruct date: 2024-06, completionDateStruct date: 2025-04, studyFirstPostDateStruct date: 2024-03-20, lastUpdatePostDateStruct date: 2024-03-20, sponsorCollaboratorsModule leadSponsor name: Arizona State University, class: OTHER, descriptionModule briefSummary: When linking dietary interventions and blood glucose management, much of the existing research - particularly studies exploring the effects of vinegar - has relied on discrete readings from the conventional testing methods: blood samples or glucometers. These methods lack the capacity to provide insights into blood glucose dynamics 24/7.Recognizing this gap, the current study aims to utilize continuous glucose monitoring to examine the impact of daily vinegar ingestion on glucose variability in adults identified as glucose intolerant., conditionsModule conditions: Glucose Intolerance, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: CROSSOVER, interventionModelDescription: This is a 9-day trial. Participants will be fitted with a continuous glucose monitor and follow their typical diet and activity patterns. Participants will be randomized to ingest 2 tablespoons of vinegar twice daily (diluted in water) or a vinegar pill for the first 4 days on the trial. On day 5 of the trial participants will consume the alternate treatment for trial days 5-8. Dietary intake will be recorded daily using a fitness app. Physical activity will be assessed at baseline and on study day 4 and 8. On day 9, participants will return to the test site for device removal., primaryPurpose: OTHER, maskingInfo masking: SINGLE, maskingDescription: Liquid and pill vinegar will be the treatments. The pill is the 'control' as the level of acetic acid is below the amount needed for an antiglycemic effect (a fact not realized by the participant)., whoMasked: PARTICIPANT, enrollmentInfo count: 12, type: ESTIMATED, armsInterventionsModule interventions name: Liquid vinegar, interventions name: vinegar pill, outcomesModule primaryOutcomes measure: Average glucose, primaryOutcomes measure: Glucose: time in range, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: 850 PBC, status: RECRUITING, city: Phoenix, state: Arizona, zip: 85004, country: United States, contacts name: Carol S Johnston, PhD, role: CONTACT, phone: 602-965-2539, email: carol.johnston@asu.edu, geoPoint lat: 33.44838, lon: -112.07404, hasResults: False
protocolSection identificationModule nctId: NCT06319430, orgStudyIdInfo id: HS26236(H2023:343), briefTitle: Technology in Play for Children With Physical Disabilities: the Dice Model of Play, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-04-01, primaryCompletionDateStruct date: 2025-04-30, completionDateStruct date: 2025-05-28, studyFirstPostDateStruct date: 2024-03-20, lastUpdatePostDateStruct date: 2024-03-20, sponsorCollaboratorsModule leadSponsor name: University of Manitoba, class: OTHER, collaborators name: Rehabilitation Centre for Children, Canada, descriptionModule briefSummary: Play is an important activity for children. Almost all children play, but what is play? It is not easy to define play. In the past, people believed that children played to burn their energy. Now, it is known that play is important for children's growth. Some kids with disabilities cannot play. Many experts use play to teach children specific skills. People often forget that play is a child's right. It is important to help all children play. The first step is to define play and find what features are important in helping a child with a disability play.There are some models of play. But they are not complete. They do not look at play as a whole. Some models are just about playfulness, and some are about playing with others. Having a model that defines play helps researchers and clinicians think about play and the different parts of it. Then, when a child cannot play, experts can fix the part that is not working. Investigators want to introduce a model of play in this project. Investigators want to edit and complete it in three steps. First, Investigators will ask parents and children with disabilities about things that help or do not help them play; then, investigators will give Lego robots to kids that they will build with help and play with them for a few weeks. And at the end, investigators will ask therapists and other experts about our model of play. This model will be edited during the study., conditionsModule conditions: Physical Disability, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: CROSSOVER, interventionModelDescription: The primary purpose is validation of.........., primaryPurpose: OTHER, maskingInfo masking: NONE, enrollmentInfo count: 10, type: ESTIMATED, armsInterventionsModule interventions name: robots, interventions name: conventional, outcomesModule primaryOutcomes measure: Test of Playfulness, primaryOutcomes measure: The Child Initiated Pretend Play Assessment (ChIPPA-2), primaryOutcomes measure: The Pretend Play Enjoyment-Developmental Checklist (PPE-DC), eligibilityModule sex: ALL, minimumAge: 3 Years, maximumAge: 8 Years, stdAges: CHILD, contactsLocationsModule, documentSection largeDocumentModule largeDocs typeAbbrev: Prot_SAP_ICF, hasProtocol: True, hasSap: True, hasIcf: True, label: Study Protocol, Statistical Analysis Plan, and Informed Consent Form, date: 2024-01-22, uploadDate: 2024-03-04T16:47, filename: Prot_SAP_ICF_000.pdf, size: 1962440, hasResults: False
protocolSection identificationModule nctId: NCT06319417, orgStudyIdInfo id: HT-UCAM, briefTitle: Hydroxytyrosol Caramel Treatment on Cardiovascular Risk Patients, statusModule overallStatus: COMPLETED, startDateStruct date: 2022-04-15, primaryCompletionDateStruct date: 2023-03-23, completionDateStruct date: 2023-03-23, studyFirstPostDateStruct date: 2024-03-20, lastUpdatePostDateStruct date: 2024-03-20, sponsorCollaboratorsModule leadSponsor name: Universidad Católica San Antonio de Murcia, class: OTHER, descriptionModule briefSummary: The goal of this double-blind crossover randomized clinical trial is to evaluate the impact of a phenolic natural compound called hydroxytyrosol (HT) on patients at cardiovascular risk (CVR). The main questions it aims to answer are:* Evaluating the effect of HT caramels on CVR biomarkers.* Assessing the impact of HT caramels on cellular phenotype.Participants will take 4 caramels/day, each containing 15 mg of HT, consuming a daily intake of 60 mg for 28 days. One group will begin with HT caramel consumption for 28 days, while the other group will start with a placebo treatment. Following a 2-week washout period, the treatments will be switched between the groups. Those who initially consumed HT will then switch to the placebo treatment, and vice-versa, each for a duration of 28 days., conditionsModule conditions: Cardiovascular Pathology, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: CROSSOVER, interventionModelDescription: 28 days of treatment: one group with HT treatment and the other with placebo treatment.2-weeks washout period. The treatment will be switched between groups for another 28 days: those who initially consumed HT will the switch to the placebo treatment, and vice versa., primaryPurpose: TREATMENT, maskingInfo masking: DOUBLE, maskingDescription: Nor participant and care provider knew the treatment given., whoMasked: PARTICIPANT, whoMasked: CARE_PROVIDER, enrollmentInfo count: 26, type: ACTUAL, armsInterventionsModule interventions name: HT treatment, interventions name: Placebo treatment, outcomesModule primaryOutcomes measure: Change of cardiovascular biomarkers, primaryOutcomes measure: Change of cellular phenotype of platelets, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 75 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Catholic University of Murcia (UCAM), city: Murcia, zip: 30107, country: Spain, geoPoint lat: 37.98704, lon: -1.13004, documentSection largeDocumentModule largeDocs typeAbbrev: ICF, hasProtocol: False, hasSap: False, hasIcf: True, label: Informed Consent Form, date: 2022-03-01, uploadDate: 2024-03-12T10:59, filename: ICF_000.pdf, size: 995478, hasResults: False
protocolSection identificationModule nctId: NCT06319404, orgStudyIdInfo id: 2022YFC2505700, briefTitle: Immune Function of Colorectal Cancer Lymph Nodes, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-04-01, primaryCompletionDateStruct date: 2026-04-01, completionDateStruct date: 2026-04-01, studyFirstPostDateStruct date: 2024-03-20, lastUpdatePostDateStruct date: 2024-03-20, sponsorCollaboratorsModule leadSponsor name: Shanxi Province Cancer Hospital, class: OTHER, collaborators name: The Second Affiliated Hospital of Harbin Medical University, collaborators name: Cancer Institute and Hospital, Chinese Academy of Medical Sciences, descriptionModule briefSummary: Lymph nodes are very important immune organs in the human body and play an important role in the physiological and pathological activities of the body, especially in anti-tumor immunity. The role of regional draining lymph nodes in the development of colorectal cancer is still unknown. In this study, the role of lymph nodes in the development of colorectal cancer was investigated through multicenter and multi-omics data., conditionsModule conditions: Colorectal Cancer, conditions: Lymph Node, designModule studyType: OBSERVATIONAL, designInfo observationalModel: OTHER, timePerspective: PROSPECTIVE, enrollmentInfo count: 500, type: ESTIMATED, armsInterventionsModule interventions, outcomesModule primaryOutcomes measure: To investigate the difference of immune pathway activation in tumor-draining lymph node based on genomics, primaryOutcomes measure: To investigate the relationship between the type and number of immune cells in tumor draining lymph nodes and the activation of immune pathways is based on pathomics, primaryOutcomes measure: The immune function of tumor draining lymph nodes of colorectal cancer patients was previously identified based on radiomics, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 75 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule, hasResults: False
protocolSection identificationModule nctId: NCT06319365, orgStudyIdInfo id: gurcansolmaz, briefTitle: Yoga on Women's Blood Pressure, Sexual Life, And Marital Compliance, statusModule overallStatus: RECRUITING, startDateStruct date: 2023-03-01, primaryCompletionDateStruct date: 2024-03-22, completionDateStruct date: 2024-03-22, studyFirstPostDateStruct date: 2024-03-20, lastUpdatePostDateStruct date: 2024-03-25, sponsorCollaboratorsModule leadSponsor name: University of Yalova, class: OTHER, descriptionModule briefSummary: Introduction This study will examine the effects of a 12-week yoga program consisting of one-hour sessions three times a week on blood pressure, sexual life and marital adjustment among hypertensive women. Hypertension can adversely affect vascular health and affect marital relationships by contributing to sexual dysfunction.Method. The study will be a pre-post test randomized controlled study in accordance with CONSORT rules. Personal Information Form, Bloood pressure measurement, Arizona Sexual Experience Scale and Marital Adjustment Test will be used for data collection., conditionsModule conditions: Hypertension, conditions: Sexuality, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: SUPPORTIVE_CARE, maskingInfo masking: NONE, enrollmentInfo count: 70, type: ESTIMATED, armsInterventionsModule interventions name: yoga, outcomesModule primaryOutcomes measure: blood presure, eligibilityModule sex: FEMALE, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Yalova University, status: RECRUITING, city: Yalova, country: Turkey, contacts name: GÜRCAN SOLMAZ, role: CONTACT, email: gurcansolmaz@hotmail.com, geoPoint lat: 40.65501, lon: 29.27693, hasResults: False
protocolSection identificationModule nctId: NCT06319352, orgStudyIdInfo id: HUM00243293, briefTitle: Evaluation of Quality-of-Life Improvements Using UroShield Device, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-05-31, primaryCompletionDateStruct date: 2024-10, completionDateStruct date: 2024-10, studyFirstPostDateStruct date: 2024-03-20, lastUpdatePostDateStruct date: 2024-04-26, sponsorCollaboratorsModule leadSponsor name: University of Michigan, class: OTHER, collaborators name: Nanovibronix, descriptionModule briefSummary: The goal of this pilot study is to test key elements of the full study that will follow, including recruitment and retention strategies, intervention delivery, laboratory testing, data collection methods, and adherence to study protocol.The main questions the investigators aim to answer focus on implementation and practicality:* Recruitment feasibility and time to recruit* How well do participants adhere to device protocol?* How often do device components (i.e., actuators and drivers) have to be replaced?* How much time is required for data collection and what sources or methods for data collection are used?Results of this pilot study will inform the investigators as to necessary protocol modifications and overall feasibility for the larger randomized clinical trial to follow., conditionsModule conditions: Quality of Life, conditions: Catheter-Associated Urinary Tract Infection, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: DEVICE_FEASIBILITY, maskingInfo masking: QUADRUPLE, whoMasked: PARTICIPANT, whoMasked: CARE_PROVIDER, whoMasked: INVESTIGATOR, whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 16, type: ESTIMATED, armsInterventionsModule interventions name: Active UroShield, interventions name: Sham UroShield, outcomesModule primaryOutcomes measure: Recruitment rate, secondaryOutcomes measure: Device use adherence, secondaryOutcomes measure: Device accountability, secondaryOutcomes measure: Efficiency of data collection, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, hasResults: False
protocolSection identificationModule nctId: NCT06319326, orgStudyIdInfo id: Postfeed Intestinal Perfusion, briefTitle: Intestinal Perfusion After Feeding in Preterm and Term Infants, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-04-02, primaryCompletionDateStruct date: 2024-06-30, completionDateStruct date: 2024-08-31, studyFirstPostDateStruct date: 2024-03-20, lastUpdatePostDateStruct date: 2024-03-20, sponsorCollaboratorsModule leadSponsor name: The Hospital for Sick Children, class: OTHER, collaborators name: Xiamen Children's Hospital, descriptionModule briefSummary: This is a pilot exploratory observational prospective cohort phase I study. In this study, we will gather preliminary data to evaluate (i) the magnitude of changes in blood flow in the bowel before and after feeding and (ii) the differences between preterm and term infants., conditionsModule conditions: Premature, conditions: Necrotizing Enterocolitis, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: PROSPECTIVE, enrollmentInfo count: 20, type: ESTIMATED, armsInterventionsModule interventions name: Evaluation of intestinal perfusion with color Doppler abdominal ultrasound before and after feeding., outcomesModule primaryOutcomes measure: Time-averaged mean velocity of the superior mesenteric artery, secondaryOutcomes measure: Bowel wall perfusion, eligibilityModule sex: ALL, maximumAge: 4 Weeks, stdAges: CHILD, contactsLocationsModule locations facility: Children's Hospital of Fudan University (Xiamen Branch), city: Xiamen, state: Fujian, zip: 361000, country: China, contacts name: Haitao Zhu, MD, role: CONTACT, phone: +86-592-2529586, email: haitao_zhu@fudan.edu.cn, contacts name: Haitao Zhu, MD, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 24.47979, lon: 118.08187, hasResults: False